| pubmed-article:2925824 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2925824 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:2925824 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
| pubmed-article:2925824 | lifeskim:mentions | umls-concept:C0000970 | lld:lifeskim |
| pubmed-article:2925824 | lifeskim:mentions | umls-concept:C0680730 | lld:lifeskim |
| pubmed-article:2925824 | lifeskim:mentions | umls-concept:C0185125 | lld:lifeskim |
| pubmed-article:2925824 | lifeskim:mentions | umls-concept:C0201734 | lld:lifeskim |
| pubmed-article:2925824 | lifeskim:mentions | umls-concept:C1148554 | lld:lifeskim |
| pubmed-article:2925824 | lifeskim:mentions | umls-concept:C0008565 | lld:lifeskim |
| pubmed-article:2925824 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:2925824 | pubmed:dateCreated | 1989-4-26 | lld:pubmed |
| pubmed-article:2925824 | pubmed:abstractText | The determination of acetaminophen in biological samples of humans who have ingested normal and overdosage of the drug is necessary to understand the clinical pharmacokinetics of acetaminophen and to determine its distribution and toxicokinetic parameters. This paper describes a rapid, simple, and sensitive high-performance liquid chromatographic method for determining acetaminophen in human plasma. Acetaminophen is isolated from plasma by adding approximately 200 microL of acetonitrile and 50 mg of solid zinc sulfate to each milliliter of plasma. A short column (60 mm x 4.6 mm) slurry packed with 5.0-microns PRP-1 particles is used with an isocratic elution of 5.0 mM dibasic potassium phosphate and 5.0 mM tetrabutylammonium hydroxide/methanol, 70:30 (v/v). The flow rate is 1.0 mL/min. The acetaminophen peak is detected with a variable wavelength ultraviolet/visible detector at 250 nm and 0.50 to 0.002 AUFS. The analysis time of the assay is less than 15 min, and the limit of detection is 20 ng/mL for an 80-microL injection volume. The pharmacokinetics of acetaminophen in plasma from a subject who had orally ingested 975 mg of the drug in tablet form is conducted using this method, and various pharmacokinetic parameters are determined. | lld:pubmed |
| pubmed-article:2925824 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2925824 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2925824 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2925824 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2925824 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2925824 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2925824 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2925824 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:2925824 | pubmed:issn | 0021-9665 | lld:pubmed |
| pubmed-article:2925824 | pubmed:author | pubmed-author:RustumA MAM | lld:pubmed |
| pubmed-article:2925824 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2925824 | pubmed:volume | 27 | lld:pubmed |
| pubmed-article:2925824 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2925824 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2925824 | pubmed:pagination | 18-22 | lld:pubmed |
| pubmed-article:2925824 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:2925824 | pubmed:meshHeading | pubmed-meshheading:2925824-... | lld:pubmed |
| pubmed-article:2925824 | pubmed:meshHeading | pubmed-meshheading:2925824-... | lld:pubmed |
| pubmed-article:2925824 | pubmed:meshHeading | pubmed-meshheading:2925824-... | lld:pubmed |
| pubmed-article:2925824 | pubmed:meshHeading | pubmed-meshheading:2925824-... | lld:pubmed |
| pubmed-article:2925824 | pubmed:meshHeading | pubmed-meshheading:2925824-... | lld:pubmed |
| pubmed-article:2925824 | pubmed:meshHeading | pubmed-meshheading:2925824-... | lld:pubmed |
| pubmed-article:2925824 | pubmed:meshHeading | pubmed-meshheading:2925824-... | lld:pubmed |
| pubmed-article:2925824 | pubmed:year | 1989 | lld:pubmed |
| pubmed-article:2925824 | pubmed:articleTitle | Determination of acetaminophen in human plasma by ion-pair reversed-phase high-performance liquid chromatography. Application to a single-dose pharmacokinetic study. | lld:pubmed |
| pubmed-article:2925824 | pubmed:affiliation | Department of Metabolism and Environmental Fate, Hazleton Laboratories America, Inc., Madison, Wisconsin 53707. | lld:pubmed |
| pubmed-article:2925824 | pubmed:publicationType | Journal Article | lld:pubmed |
